Report Overview:
The global key manufacturers of Lumbrokinase Supplement include Etta Vita, Doctor's Best, Researched Nutritionals, Double Wood Supplements, Allergy Research Group, Dr. Mercola and Absonutrix, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Lumbrokinase Supplement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lumbrokinase Supplement. This report contains market size and forecasts of Lumbrokinase Supplement in global, including the following market information:
Market Value:
The global Lumbrokinase Supplement market was valued at US$ 128.6 million in 2023 and is projected to reach US$ 200 million by 2030, at a CAGR of 6.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. CAGR of 6.5%
(2022 – 2029)
By Types:
•60 Capsules
•120 Capsules
•Others
By Applications: Pharmacy
Supermarkets
Online Stores
Hospitals and Clinics
Key players include:
•Taiwan Huanuo
•Conscientia Industrial
•Wuhan Hengheda Pharm Co., Ltd.
•Shaanxi Yuantai Biological Technology Co., Ltd.
•Shaanxi Greenyo Biotech Co., Ltd.
•Xi'an Sonwu Biotech Co., Ltd.
